265 related articles for article (PubMed ID: 10515888)
1. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells.
Estrov Z; Shishodia S; Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Aggarwal BB
Blood; 2003 Aug; 102(3):987-95. PubMed ID: 12689943
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation.
Estrov Z; Black RA; Sleath PR; Harris D; Van Q; LaPushin R; Estey EH; Talpaz M
Blood; 1995 Dec; 86(12):4594-602. PubMed ID: 8541550
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.
Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Estrov Z
Blood; 2003 Jul; 102(2):630-7. PubMed ID: 12663443
[TBL] [Abstract][Full Text] [Related]
5. WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).
Faderl S; Ferrajoli A; Harris D; Van Q; Priebe W; Estrov Z
Anticancer Res; 2005; 25(3B):1841-50. PubMed ID: 16158916
[TBL] [Abstract][Full Text] [Related]
6. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta.
Newton R; Kuitert LM; Bergmann M; Adcock IM; Barnes PJ
Biochem Biophys Res Commun; 1997 Aug; 237(1):28-32. PubMed ID: 9266823
[TBL] [Abstract][Full Text] [Related]
7. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
[TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.
Singh S; Aggarwal BB
J Biol Chem; 1995 May; 270(18):10631-9. PubMed ID: 7738000
[TBL] [Abstract][Full Text] [Related]
10. The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation.
Sun Q; Matta H; Chaudhary PM
Blood; 2003 Mar; 101(5):1956-61. PubMed ID: 12406869
[TBL] [Abstract][Full Text] [Related]
11. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes.
Oda M; Sakitani K; Kaibori M; Inoue T; Kamiyama Y; Okumura T
J Biol Chem; 2000 Feb; 275(6):4369-73. PubMed ID: 10660607
[TBL] [Abstract][Full Text] [Related]
12. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
[TBL] [Abstract][Full Text] [Related]
13. Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.
Carter BZ; Kornblau SM; Tsao T; Wang RY; Schober WD; Milella M; Sung HG; Reed JC; Andreeff M
Blood; 2003 Dec; 102(12):4179-86. PubMed ID: 12920030
[TBL] [Abstract][Full Text] [Related]
14. Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
Faderl S; Pal A; Bornmann W; Albitar M; Maxwell D; Van Q; Peng Z; Harris D; Liu Z; Hazan-Halevy I; Kantarjian HM; Estrov Z
Cancer Res; 2009 May; 69(9):3910-7. PubMed ID: 19383925
[TBL] [Abstract][Full Text] [Related]
15. CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts.
Aldinucci D; Poletto D; Nanni P; Degan M; Rupolo M; Pinto A; Gattei V
Exp Hematol; 2002 Nov; 30(11):1283-92. PubMed ID: 12423681
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1beta maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways.
Turzanski J; Grundy M; Russell NH; Pallis M
Leukemia; 2004 Oct; 18(10):1662-70. PubMed ID: 15306822
[TBL] [Abstract][Full Text] [Related]
17. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.
Takada Y; Andreeff M; Aggarwal BB
Blood; 2005 Jul; 106(2):641-9. PubMed ID: 15811958
[TBL] [Abstract][Full Text] [Related]
18. Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias.
Poggi A; Pellegatta F; Leone BE; Moretta L; Zocchi MR
Eur J Immunol; 2000 Oct; 30(10):2751-8. PubMed ID: 11069054
[TBL] [Abstract][Full Text] [Related]
19. A PARP-1/JNK1 cascade participates in the synergistic apoptotic effect of TNFalpha and all-trans retinoic acid in APL cells.
Mathieu J; Flexor M; Lanotte M; Besançon F
Oncogene; 2008 May; 27(24):3361-70. PubMed ID: 18084321
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
